$AMIX News

Autonomix Medical Strengthens Patent Protection for Platform Technology Enabling Precision Access, Treatment Delivery and Procedural Validation

Autonomix Reports Positive FDA Feedback Supporting 510(k) Pathway to U.S. Clearance

Autonomix Medical Completes Pre-Submission Meeting With FDA For Its Transvascular Sensing Platform

Autonomix Medical Expands Global Intellectual Property Footprint with European Patent Supporting Precision Neuromodulation Platform

Autonomix Medical Receives European Patent Titled Systems For Assessing Neural Activity In An Eye

Autonomix Medical Announces Acceptance of Two Abstracts for Poster Presentation at CIRSE 2026

Autonomix Medical Expands Intellectual Property Portfolio with New U.S. Patent Covering Feedback-Guided Precision Neuromodulation and Targeted Therapy Delivery

Autonomix Medical Announces Issuance Of U.S. Patent Titled 'Systems And Methods For Regulating Organ And/Or Tumor Growth Rates, Function, And/Or Development' On August 25

Autonomix Medical (AMIX) Stock Surges 117% After Hours: Here’s Why

Autonomix Medical Enters into $4.9 Million Warrant Inducement Priced at a Premium to Market Under Nasdaq Rules

Autonomix Medical Will Be Granted U.S. Patent No. 12,714,780 Tomorrow (August 25, 2026), Titled “Systems and Methods for Regulating Organ and/or Tumor Growth Rates, Function, and/or Development.”

Autonomix Medical Q1 EPS $(5.02) Beats $(6.93) Estimate

Autonomix Medical Completes Good Laboratory Practice (GLP) Preclinical Study, Marking Key Step Toward FDA Submission

Autonomix Stock Skyrockets After Obtaining Key Cancer Tech Patent

Autonomix Medical Receives U.S. Patent for Precision Neuromodulation Platform Expansion

Autonomix Medical Expands Precision Neuromodulation Platform with Broad New U.S. Patent Supporting Nerve Sensing, Mapping and Targeted Therapy

Autonomix Medical Granted U.S. Patent Titled 'Systems And Methods For Treating Cancer And/Or Augmenting Organ Function'

Autonomix Medical (AMIX) Stock Rallies Over 54% After Hours: Here's Why

Autonomix Medical Demonstrates Renal Nerve Sensing and Neural Activity Change in Preclinical Study

Autonomix Medical Announces Results From Preclinical Study Demonstrating Ability Of Its Neural Sensing Platform To Detect, Localize And Confirm Changes In Renal Neural Activity